These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 1664901)
21. Sentinel lymph node biopsy in breast cancer New indications and our experience. Zanghì G; Rinzirillo NM; Caponnetto AM; Vecchio R; Catania V; Leanza V Ann Ital Chir; 2015; 86():508-12. PubMed ID: 26898363 [TBL] [Abstract][Full Text] [Related]
22. Internal mammary chain sentinel lymph node identification in breast cancer. Noguchi M; Tsugawa K; Miwa K J Surg Oncol; 2000 Feb; 73(2):75-80. PubMed ID: 10694642 [TBL] [Abstract][Full Text] [Related]
23. [Lobular invasive breast cancer prognostic factors: About 940 patients]. Jauffret C; Houvenaeghel G; Classe JM; Garbay JR; Giard S; Charitansky H; Cohen M; Bélichard C; Faure C; Darai É; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Martino M; Coutant C; Dravet F; Chauvet MP; Chéreau Ewald E; Penault-Llorca F; Goncalves A; Lambaudie É Gynecol Obstet Fertil; 2015 Nov; 43(11):712-7. PubMed ID: 26482833 [TBL] [Abstract][Full Text] [Related]
24. Risk factors for regional nodal failure after breast-conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes. Grills IS; Kestin LL; Goldstein N; Mitchell C; Martinez A; Ingold J; Vicini FA Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):658-70. PubMed ID: 12788171 [TBL] [Abstract][Full Text] [Related]
25. Axillary biopsy compared with dissection in the staging of lymph nodes in operable breast cancer. A randomised trial. Christensen SB; Jansson C Eur J Surg; 1993 Mar; 159(3):159-62. PubMed ID: 8102890 [TBL] [Abstract][Full Text] [Related]
26. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases]. Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002 [TBL] [Abstract][Full Text] [Related]
27. [Efficacy of extrapleural internal mammary node dissection in breast cancer]. Kohno N; Motizuki K; Imanaka Y; Nakamura M; Wada T; Yamamoto K; Furuya Y; Nakazawa T; Takao K; Saitoh Y Gan No Rinsho; 1986 Sep; 32(11):1400-6. PubMed ID: 3773268 [TBL] [Abstract][Full Text] [Related]
28. The prognostic value of sentinel lymph node micrometastases in patients with invasive breast carcinoma. Cipolla C; Graceffa G; La Mendola R; Fricano S; Fricano M; Vieni S Ann Ital Chir; 2015; 86():497-502. PubMed ID: 26898168 [TBL] [Abstract][Full Text] [Related]
29. Sentinel node biopsy versus low axillary sampling in women with clinically node negative operable breast cancer. Parmar V; Hawaldar R; Nair NS; Shet T; Vanmali V; Desai S; Gupta S; Rangrajan V; Mittra I; Badwe RA Breast; 2013 Dec; 22(6):1081-6. PubMed ID: 23948301 [TBL] [Abstract][Full Text] [Related]
30. FDG-PET for axillary lymph node staging in primary breast cancer. Crippa F; Gerali A; Alessi A; Agresti R; Bombardieri E Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S97-102. PubMed ID: 15133635 [TBL] [Abstract][Full Text] [Related]
31. [The effect of axillary lymph node status on the prognosis of patients with local-regional recurrence after breast-conserving surgery]. Zhang Z; Zhang W; Li ZJ; Wang XM; Cao XC; Xiao CH Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):347-351. PubMed ID: 29860761 [No Abstract] [Full Text] [Related]
32. Prognosis of breast cancer: evidence for interaction between c-erbB-2 overexpression and number of involved axillary lymph nodes. Mittra I; Redkar AA; Badwe RA J Surg Oncol; 1995 Oct; 60(2):106-11. PubMed ID: 7564375 [TBL] [Abstract][Full Text] [Related]
33. [Axillary node removal in clinical node-negative breast carcinoma. Can its indication be individualized by "sentinel node" detection?]. Reuhl T; Kaisers H; Markwardt J; Haensch W; Hohenberger P; Schlag PM Dtsch Med Wochenschr; 1998 May; 123(19):583-7. PubMed ID: 9618639 [TBL] [Abstract][Full Text] [Related]
34. Prognostic value of extracapsular invasion of axillary lymph nodes combined with peritumoral vascular invasion in patients with breast cancer. Yajima R; Fujii T; Yanagita Y; Fujisawa T; Miyamoto T; Hirakata T; Tsutsumi S; Iijima M; Kuwano H Ann Surg Oncol; 2015 Jan; 22(1):52-8. PubMed ID: 25059790 [TBL] [Abstract][Full Text] [Related]
35. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients? Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642 [TBL] [Abstract][Full Text] [Related]
36. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial]. Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111 [TBL] [Abstract][Full Text] [Related]
37. [Axillary lymph nodes in breast cancer. Comparison of standard histological analytical technics and macroscopic serial sections]. de Mascarel I; Trojani M; Abadjian G; Durand M; Bonichon F; Coindre JM; Meuge-Moraw C Bull Cancer; 1982; 69(5):451-5. PubMed ID: 6762234 [TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer. Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997 [TBL] [Abstract][Full Text] [Related]
39. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection. Kamath VJ; Giuliano R; Dauway EL; Cantor A; Berman C; Ku NN; Cox CE; Reintgen DS Arch Surg; 2001 Jun; 136(6):688-92. PubMed ID: 11387010 [TBL] [Abstract][Full Text] [Related]
40. Level III axillary lymph nodes involvement in node positive breast cancer received neoadjuvant chemotherapy. Fan Z; Li J; Wang T; Xie Y; Fan T; Lin B; Ouyang T Breast; 2013 Dec; 22(6):1161-5. PubMed ID: 24080493 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]